Literature DB >> 17641847

Altered nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone nutritional support therapy.

Yanqing Guo1, Xiangjun Bai, Guanyu Lin, Zhaohui Tang.   

Abstract

In order to observe the nutrition state in the severe multiple trauma patients undergoing adjuvant recombinant human growth hormone (rhGH) nutritional support therapy, 45 patients with severe multiple traumas (ISS>25) were randomly divided into 3 groups. All the 3 groups had been supplied with nitrogen and caloricity according to the need of patients for 16 days. The rhGH therapy started 48 h after surgery and lasted for 14 days in two rhGH-treated groups in which rhGH was 0.2 and 0.4 U/(kg . d) respectively, and the resting group served as control one. The levels of nitrogen balance, prealbumin and safety variables (blood sugar, Na+, TT3 and TT4) were observed and compared among the three groups. The levels of nitrogen balance on the postoperative day (POD) 3 and 5 in the rhGH-treated groups were -1.28+/-3.19, 5.45+/-2.00 and -0.18+/-2.55, 6.11+/-1.60, respectively, which were significantly higher than those in the control group (-5.17+/-1.68 and -1.08+/-3.31, P<0.01). The values of prealbumin on the POD 3 and 5 in the rhGH-treated groups were 180.19+/-27.15, 194.44+/-50.82 and 194.94+/-29.65, 194.11+/-16.17, respectively, which were significantly higher than those in the control group (117.42+/-19.10 and 135.63+/-28.31, P<0.01). There was no significant difference between the rhGH 0.2 U/(kg . d) group and rhGH 0.4 U/(kg . d) group in both of the levels of nitrogen balance and prealbumin. It is concluded that the nutritional support therapy with adjuvant rhGH which starts 48 h after surgery improves the nutrition state of the patients with severe multiple trauma. It is safe for severe multiple trauma patients who accept rhGH at the dose of 0.2 and 0.4 U/(kg . d).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641847     DOI: 10.1007/s11596-007-0321-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Increased mortality associated with growth hormone treatment in critically ill adults.

Authors:  K J Osterziel; R Dietz; M B Ranke
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

Review 2.  Gut dysfunction in critically ill patients: a review of the literature.

Authors:  J K Stechmiller; D Treloar; N Allen
Journal:  Am J Crit Care       Date:  1997-05       Impact factor: 2.228

3.  Practice management guidelines for nutritional support of the trauma patient.

Authors:  David G Jacobs; Danny O Jacobs; Kenneth A Kudsk; Frederick A Moore; Michael F Oswanski; Galen V Poole; Gordon Sacks; L R Tres Scherer; Karlene E Sinclair
Journal:  J Trauma       Date:  2004-09

4.  Decreased growth hormone levels in the catabolic phase of severe injury.

Authors:  M Jeevanandam; L Ramias; R F Shamos; W R Schiller
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

5.  Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis.

Authors:  L D Plank; A B Connolly; G L Hill
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

6.  Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet.

Authors:  S Lundeberg; M Belfrage; J Wernerman; A von der Decken; S Thunell; E Vinnars
Journal:  Metabolism       Date:  1991-03       Impact factor: 8.694

7.  Effects of growth hormone and insulin-like growth factor-1 on protein metabolism, gut morphology, and cell-mediated immunity in burned rats.

Authors:  N Shimoda; T Tashiro; H Yamamori; K Takagi; N Nakajima; I Ito
Journal:  Nutrition       Date:  1997-06       Impact factor: 4.008

8.  Can the use of growth hormone reduce the postoperative fatigue syndrome?

Authors:  R Vara-Thorbeck; J A Guerrero; E Ruiz-Requena; M García-Carriazo
Journal:  World J Surg       Date:  1996-01       Impact factor: 3.352

9.  Growth hormone reduces bacterial translocation in radiation enteritis in the rat.

Authors:  I Prieto; I A Gómez de Segura; A García Grande; A Guerra; F Pozo; P García; E de Miguel
Journal:  Rev Esp Enferm Dig       Date:  1998-05       Impact factor: 2.086

10.  Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns.

Authors:  D N Herndon; H K Hawkins; T T Nguyen; E Pierre; R Cox; R E Barrow
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.